IPSEN |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 113 EUR | +0.62% |
|
+4.24% | +4.73% |
| Apr. 24 | IPSEN : Better-than-expected Q1; guidance unchanged |  |
| Apr. 24 | Transcript : Ipsen S.A., Q1 2024 Sales/ Trading Statement Call, Apr 24, 2024 |
ETFs positioned on Ipsen
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.83% | 2 M€ | +7.72% | ||
| 0.43% | 182 M€ | +6.98% | ||
| 0.31% | 3 M€ | +9.95% | - | |
| 0.24% | 1,120 M€ | +0.40% | ||
| 0.24% | 5 M€ | +4.56% | ||
| 0.16% | 5 M€ | +10.09% | - | |
| 0.16% | 14 M€ | +5.66% | - | |
| 0.10% | 2 M€ | +9.19% | - | |
| 0.10% | 2 M€ | -.--% | - | |
| 0.09% | 18 M€ | +3.79% | - | |
| 0.05% | 6 M€ | -.--% | - | |
| 0.04% | 6 M€ | -.--% | ||
| 0.03% | 31 M€ | +3.50% | - | |
| 0.03% | 10 M€ | -3.35% | - | |
| 0.02% | 7 M€ | +0.11% | - | |
| 0.02% | 23 M€ | -.--% | - | |
| 0.02% | 786 M€ | -.--% | ||
| 0.01% | 206 M€ | -.--% | ||
| 0.01% | 607 M€ | +0.05% | - | |
| 0.01% | 1,166 M€ | +0.26% | - | |
| 0.01% | 273 M€ | +15.83% | ||
| 0.00% | 284 M€ | -.--% | ||
| 0.00% | 389 M€ | +6.83% | - | |
| 0.00% | 34 M€ | +4.85% | - | |
| 0.00% | 34 M€ | +2.14% | - |
Ipsen specialises in the research, development, manufacture and marketing of specialty medicines. Net sales by therapeutic area break down as follows:
- oncology (75.2%);
- neuroscience (21.1%);
- rare diseases (3.7%).
At the end of 2023, the group had 4 research and development centres located in France, the United Kingdom, the United States and China, and 4 manufacturing sites worldwide.
Net sales are distributed geographically as follows: Europe (40.2%), North America (33.3%) and other (26.5%).
Sector
Pharmaceuticals
Calendar
2024-05-27
- Annual General Meeting
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
113
EUR
Average target price
125.1
EUR
Spread / Average Target
+10.70%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +4.73% | 9.96B | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
- Stock Market
- Equities
- IPN Stock
- Funds and ETFs Ipsen
